Ghent University Academic Bibliography

Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01

Ditte JA Lohmann, Peter H Asdahl, Jonas Abrahamsson, Shau-Yin Ha, Olafur G Jonsson, Gertjan JL Kaspers, Minna Koskenvuo, Birgitte Lausen, Barbara De Moerloose (UGent) , Josefine Palle, et al.

(2019) PEDIATRIC BLOOD & CANCER. 66(6).

Add to list

Journal Article
A1
open access

Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia

Ditte JA Lohmann, Peter H Asdahl, Jonas Abrahamsson, Shau-Yin Ha, Olafur G Jonsson, Gertjan JL Kaspers, Minna Koskenvuo, Birgitte Lausen, Barbara De Moerloose (UGent) , Josefine Palle, et al.

(2019) CANCER MEDICINE. 8(15). p.6634-6643

Add to list

Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfurt-Munster (I-BFM) study group

Kim Klein, Henrik Hasle, Jonas Abrahamsson, Barbara De Moerloose (UGent) and Gertjan J. L. Kaspers

(2018) BRITISH JOURNAL OF HAEMATOLOGY. 183(1). p.87-95

Add to list

Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia

Ditte JA Løhmann, Peter H Asdahl, Jonas Abrahamsson, Shau-Yin Ha, Ólafur G Jónsson, Gertjan JL Kaspers, Minna Koskenvuo, Birgitte Lausen, Barbara De Moerloose (UGent) , Josefine Palle, et al.

(2018) PEDIATRIC BLOOD & CANCER. 65(9).

Add to list

Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study

Ninna Bager, Kristian L. Juul-Dam, Julie D. Sandahl, Jonas Abrahamsson, Berna Beverloo, Eveline S. J. M. de Bont, Shau-Yin Ha, Kirsi Jahnukainen, Olafur G. Jonsson, Gertjan L. Kaspers, et al.

(2018) BRITISH JOURNAL OF HAEMATOLOGY. 183(4). p.618-628

Add to list

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML : a retrospective study by the I-BFM Study Group

Sanne Noort, Martin Zimmermann, Dirk Reinhardt, Wendy Cuccuini, Martina Pigazzi, Jenny Smith, Rhonda E. Ries, Todd A. Alonzo, Betsy Hirsch, Daisuke Tomizawa, et al.

(2018) BLOOD. 132(15). p.1584-1592

Add to list

Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups

Ursula Creutzig, Michael N Dworzak, Martin Zimmermann, Dirk Reinhardt, Lucie Sramkova, Jan Pierre Bourquin, Henrik Hasle, Jonas Abrahamsson, Gertjan Kaspers, Mary M van den Heuvel, et al.

(2017) PEDIATRIC BLOOD & CANCER. 64(12).

Add to list

Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents

Marcin W Wlodarski, Shinsuke Hirabayashi, Victor Pastor, Jan Starý, Henrik Hasle, Riccardo Masetti, Michael Dworzak, Markus Schmugge, Marry van den Heuvel-Eibrink, Marek Ussowicz, et al.

(2016) BLOOD. 127(11). p.1387-1397

Add to list

Collaborative efforts driving progress in pediatric acute myeloid leukemia

C Michel Zwaan, Edward A Kolb, Dirk Reinhardt, Jonas Abrahamsson, Souichi Adachi, Richard Aplenc, Eveline SJM De Bont, Barbara De Moerloose (UGent) , Michael Dworzak, Brenda ES Gibson, et al.

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(27). p.2949-U40

Add to list

Anthracycline type during induction associated with outcome in pediatric t(8;21) and inv(16) AML

Henrik Hasle, Jonas Abrahamsson, Evelina S De Bont, Valerie de Haas, Barbara De Moerloose (UGent) , Erik Forestier, Shau Yin Ha, Jesper Heldrup, Kirsi Jahnukainen, Olafur G Jonsson, et al.

(2014) BLOOD. 124(21).

Academic Bibliography

Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01

Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia

Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfurt-Munster (I-BFM) study group

Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia

Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML : a retrospective study by the I-BFM Study Group

Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups

Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents

Collaborative efforts driving progress in pediatric acute myeloid leukemia

Anthracycline type during induction associated with outcome in pediatric t(8;21) and inv(16) AML

Contents

Support

Contact